{"content":"<li class=\"n-box-item date-title\" data-end=\"1364356799\" data-start=\"1364270400\" data-txt=\"Friday, December 20, 2019\">Tuesday, March 26, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"911291\" data-ts=\"1364342996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Venaxis Inc. (APPY) climbs in the post-trade session after providing an update on its clinical...</a></h4><p>Venaxis Inc. (APPY) climbs in the post-trade session after providing an update on its clinical and commercial activities, reporting in its <a href=\"http://www.sec.gov/Archives/edgar/data/1167419/000107997313000206/appy_10k-123112.htm\" target=\"_blank\">10-K</a> that it continues to enroll patients into its ongoing clinical study of APPY1, and it anticipates completing the study and potentially filing with the FDA for regulatory clearance by year end. Read more on its Business Update Conference Call Here: <a href=\"https://seekingalpha.com/article/1302581-venaxis-management-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">Business Update Transcript</a>. Shares <font color=\"green\">+5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"911291\" data-linked=\"Venaxis Inc. (APPY) climbs in the post-trade session after providing an update on its clinical...\" data-tweet=\"$RIOT - Venaxis Inc. (APPY) climbs in the post-trade session after providing an update on its clinical and commercial activities, reporting in its 10-K that it continues to enroll patients into its ongoing clinical study of APPY1, and it anticipates com... https://seekingalpha.com/news/911291?source=tweet\" data-url=\"https://seekingalpha.com/news/911291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911281\" data-ts=\"1364341167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDOS\" target=\"_blank\">LDOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on SAIC (SAI): Q4 comes in line on revenue and beats on a per share basis as total revenue...</a></h4><p>More on SAIC (SAI): <a href=\"https://seekingalpha.com/market_currents/post/910821\" target=\"_blank\">Q4 comes in line</a> on revenue and beats on a per share basis as total revenue rose by 9.7% Y/Y. Net earnings also swung to a profit, as the government-services contractor grew its revenue and while the comparative year-earlier period was hurt by provisions. For FY13, the company projects an EPS of between $1.16 - $1.33 on revenue of around $10B - $10.7B. Analysts are looking for $1.27 a share $10.81B, respectively. Shares <font color=\"green\">+4%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"911281\" data-linked=\"More on SAIC (SAI): Q4 comes in line on revenue and beats on a per share basis as total revenue...\" data-tweet=\"$LDOS - More on SAIC (SAI): Q4 comes in line on revenue and beats on a per share basis as total revenue rose by 9.7% Y/Y. Net earnings also swung to a profit, as the government-services contractor grew its revenue and while the comparative year-earlier ... https://seekingalpha.com/news/911281?source=tweet\" data-url=\"https://seekingalpha.com/news/911281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911231\" data-ts=\"1364336107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHE\" target=\"_blank\">RHE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AdCare Health Systems (ADK) postpones its Q4 earnings release and conference call originally...</a></h4><p>AdCare Health Systems (ADK) postpones its Q4 earnings release and conference call originally scheduled for March 27, saying that it intends to restate its financial statements for the quarters ended March 31, 2012, June 30, 2012 and September 30, 2012, due to errors. It has not set a new date for its Q4 results release. Shares <font color=\"red\">-7.2%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"911231\" data-linked=\"AdCare Health Systems (ADK) postpones its Q4 earnings release and conference call originally...\" data-tweet=\"$RHE - AdCare Health Systems (ADK) postpones its Q4 earnings release and conference call originally scheduled for March 27, saying that it intends to restate its financial statements for the quarters ended March 31, 2012, June 30, 2012 and September 30,... https://seekingalpha.com/news/911231?source=tweet\" data-url=\"https://seekingalpha.com/news/911231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911181\" data-ts=\"1364334358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: MXWL +9%. SAI +4%. OWW +3%. SPLK +3%. SUPN +3%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a> <font color=\"green\">+9%</font>. SAI <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/OWW' title='Orbitz Worldwide, Inc.'>OWW</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/SUPN' title='Supernus Pharmaceuticals, Inc.'>SUPN</a> <font color=\"green\">+3%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/LNDC' title='Landec Corporation'>LNDC</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/ACMP' title='Access Midstream Partners, L.P.'>ACMP</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a> <font color=\"red\">-3%</font>.<div class=\"tiny-share-widget\" data-id=\"911181\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: MXWL +9%. SAI +4%. OWW +3%. SPLK +3%. SUPN +3%....\" data-tweet=\"$MXWL $MXWL $LDOS - After-hours top gainers, as of 5:15 p.m.: MXWL +9%. SAI +4%. OWW +3%. SPLK +3%. SUPN +3%. After-hours top losers: LNDC -8%. ACMP -4%. EOG -4%. PXD -3%. LOGM -3%. https://seekingalpha.com/news/911181?source=tweet\" data-url=\"https://seekingalpha.com/news/911181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911061\" data-ts=\"1364332679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVR\" target=\"_blank\">DOVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover Saddlery (NASDAQ:DOVR): Q4 EPS of $0.16. Revenue of $26.4M (+11% Y/Y). Shares +6.3% AH. (PR)</a></h4><b>Dover Saddlery (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DOVR\" title=\"Dover Saddlery, Inc.\">DOVR</a>):</b> Q4 EPS of $0.16. Revenue of $26.4M (+11% Y/Y). Shares  <font color=\"green\">+6.3%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"911061\" data-linked=\"Dover Saddlery (NASDAQ:DOVR): Q4 EPS of $0.16. Revenue of $26.4M (+11% Y/Y). Shares +6.3% AH. (PR)\" data-tweet=\"$DOVR - Dover Saddlery (NASDAQ:DOVR): Q4 EPS of $0.16. Revenue of $26.4M (+11% Y/Y). Shares +6.3% AH. (PR) https://seekingalpha.com/news/911061?source=tweet\" data-url=\"https://seekingalpha.com/news/911061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910991\" data-ts=\"1364331578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISNS\" target=\"_blank\">ISNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Image Sensing Systems (NASDAQ:ISNS): Q4 EPS of $0.03 may not be comparable to consensus of...</a></h4><b>Image Sensing Systems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ISNS\" title=\"Image Sensing Systems, Inc.\">ISNS</a>):</b> Q4 EPS of $0.03 may not be comparable to consensus of $0.20. Revenue of $6.82M <font color=\"red\">misses by $0.17M</font>. Shares  <font color=\"red\">-20.5%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"910991\" data-linked=\"Image Sensing Systems (NASDAQ:ISNS): Q4 EPS of $0.03 may not be comparable to consensus of...\" data-tweet=\"$ISNS - Image Sensing Systems (NASDAQ:ISNS): Q4 EPS of $0.03 may not be comparable to consensus of $0.20. Revenue of $6.82M misses by $0.17M. Shares -20.5% AH. (PR) https://seekingalpha.com/news/910991?source=tweet\" data-url=\"https://seekingalpha.com/news/910991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910981\" data-ts=\"1364331289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Ally (NASDAQ:DGLY): Q4 EPS of -$0.24. Revenue of $4.63M. Shares -1.8% AH. (PR)</a></h4><b>Digital Ally (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DGLY\" title=\"Digital Ally, Inc.\">DGLY</a>):</b> Q4 EPS of -$0.24. Revenue of $4.63M. Shares  <font color=\"red\">-1.8%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"910981\" data-linked=\"Digital Ally (NASDAQ:DGLY): Q4 EPS of -$0.24. Revenue of $4.63M. Shares -1.8% AH. (PR)\" data-tweet=\"$DGLY - Digital Ally (NASDAQ:DGLY): Q4 EPS of -$0.24. Revenue of $4.63M. Shares -1.8% AH. (PR) https://seekingalpha.com/news/910981?source=tweet\" data-url=\"https://seekingalpha.com/news/910981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910931\" data-ts=\"1364330814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Anthera Pharmaceuticals (OTC:ANTH): Q4 EPS loss beats on a per share basis as total...</a></h4><p>More on Anthera Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ANTH\" title=\"Anthera Pharmaceuticals, Inc.\">OTC:ANTH</a>): <a href=\"https://seekingalpha.com/market_currents/post/910841\" target=\"_blank\">Q4 EPS</a> loss beats on a per share basis as total sales jumped 85% Y/Y. Operating expenses declined, due primarily to the reduced clinical activity following the completion of its Pearl-SC study. Shares <font color=\"green\">+1.6%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"910931\" data-linked=\"More on Anthera Pharmaceuticals (OTC:ANTH): Q4 EPS loss beats on a per share basis as total...\" data-tweet=\"$ANTH - More on Anthera Pharmaceuticals (OTC:ANTH): Q4 EPS loss beats on a per share basis as total sales jumped 85% Y/Y. Operating expenses declined, due primarily to the reduced clinical activity following the completion of its Pearl-SC study. Shares ... https://seekingalpha.com/news/910931?source=tweet\" data-url=\"https://seekingalpha.com/news/910931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910861\" data-ts=\"1364329649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACMP\" target=\"_blank\">ACMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Access Midstream Partners (NYSE:ACMP) -4.1% AH after announcing a public offering of 9M common...</a></h4><p>Access Midstream Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/ACMP\" title=\"Access Midstream Partners, L.P.\">ACMP</a>) <font color=\"red\">-4.1%</font> AH after announcing a public offering of 9M common units. ACMP plans to use net proceeds for general partnership  purposes, including paying down debt.</p><div class=\"tiny-share-widget\" data-id=\"910861\" data-linked=\"Access Midstream Partners (NYSE:ACMP) -4.1% AH after announcing a public offering of 9M common...\" data-tweet=\"$ACMP - Access Midstream Partners (NYSE:ACMP) -4.1% AH after announcing a public offering of 9M common units. ACMP plans to use net proceeds for general partnership purposes, including paying down debt. https://seekingalpha.com/news/910861?source=tweet\" data-url=\"https://seekingalpha.com/news/910861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910831\" data-ts=\"1364329543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS and Lionsgate (LGF) confirm the sale of a 50% stake in TV Guide Network (TVGN) and...</a></h4><a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> and Lionsgate (LGF) confirm the sale of a 50% stake in TV Guide Network (TVGN) and TVGuide.com from JPMorgan's P-E arm to CBS. CBS and Lionsgate (still a 50% owner) boast TV Guide will have access to CBS' \"programming, production and marketing assets,\" and Lionsgate's \"resources in motion pictures, television and digitally delivered content.\"Â  The price is undisclosed; sources recently told <em>The Hollywood Reporter</em> it's <a href=\"http://www.hollywoodreporter.com/news/cbs-circling-deal-acquire-tv-430467\" target=\"_blank\">around $100M</a>. LGF <font color=\"green\">+4.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"910831\" data-linked=\"CBS and Lionsgate (LGF) confirm the sale of a 50% stake in TV Guide Network (TVGN) and...\" data-tweet=\"$CBS $VIAC $LGF.A - CBS and Lionsgate (LGF) confirm the sale of a 50% stake in TV Guide Network (TVGN) and TVGuide.com from JPMorgan&#39;s P-E arm to CBS. CBS and Lionsgate (still a 50% owner) boast TV Guide will have access to CBS&#39; &quot;programming, production... https://seekingalpha.com/news/910831?source=tweet\" data-url=\"https://seekingalpha.com/news/910831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910821\" data-ts=\"1364328882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDOS\" target=\"_blank\">LDOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAIC (SAI): Q4 EPS of $0.54 beats by $0.06. Revenue of $2.71B in-line. Shares +1.9% AH. (PR)</a></h4><b>SAIC (SAI):</b> Q4 EPS of $0.54 <font color=\"green\">beats by $0.06</font>. Revenue of $2.71B<font color=\"black\"> in-line</font>. Shares  <font color=\"green\">+1.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"910821\" data-linked=\"SAIC (SAI): Q4 EPS of $0.54 beats by $0.06. Revenue of $2.71B in-line. Shares +1.9% AH. (PR)\" data-tweet=\"$LDOS - SAIC (SAI): Q4 EPS of $0.54 beats by $0.06. Revenue of $2.71B in-line. Shares +1.9% AH. (PR) https://seekingalpha.com/news/910821?source=tweet\" data-url=\"https://seekingalpha.com/news/910821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910801\" data-ts=\"1364328655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFRM\" target=\"_blank\">MFRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattress Firm (NASDAQ:MFRM): Q4 EPS of $0.30 misses by $0.03. Revenue of $258.2M (+37% Y/Y)...</a></h4><b>Mattress Firm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a>):</b> Q4 EPS of $0.30 <font color=\"red\">misses by $0.03</font>. Revenue of $258.2M (+37% Y/Y) <font color=\"red\">misses by $3.34M</font>. Shares  <font color=\"red\">-2.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"910801\" data-linked=\"Mattress Firm (NASDAQ:MFRM): Q4 EPS of $0.30 misses by $0.03. Revenue of $258.2M (+37% Y/Y)...\" data-tweet=\"$MFRM - Mattress Firm (NASDAQ:MFRM): Q4 EPS of $0.30 misses by $0.03. Revenue of $258.2M (+37% Y/Y) misses by $3.34M. Shares -2.9% AH. (PR) https://seekingalpha.com/news/910801?source=tweet\" data-url=\"https://seekingalpha.com/news/910801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910771\" data-ts=\"1364328508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGM\" target=\"_blank\">LOGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A Virginia federal jury has cleared LogMeIn (LOGM +19.6%) of infringing a remote PC access...</a></h4><p>A Virginia federal jury has cleared LogMeIn (<a href=\"https://seekingalpha.com/symbol/LOGM\" title=\"LogMeIn, Inc.\">LOGM</a> <font color=\"green\">+19.6%</font>) of infringing a remote PC access patent asserted by 01 Communique. LogMeIn's victory could have implications for <a href=\"http://www.prnewswire.com/news-releases/01-communique-files-a-patent-infringement-lawsuit-against-citrix-systems-inc-55158992.html\" target=\"_blank\">01's suit</a> against thin client/PC virtualization software leader Citrix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a>). (PR) (<a href=\"https://seekingalpha.com/currents/post/910721\" target=\"_blank\">earlier</a>)</p><div class=\"tiny-share-widget\" data-id=\"910771\" data-linked=\"A Virginia federal jury has cleared LogMeIn (LOGM +19.6%) of infringing a remote PC access...\" data-tweet=\"$LOGM $LOGM $CTXS - A Virginia federal jury has cleared LogMeIn (LOGM +19.6%) of infringing a remote PC access patent asserted by 01 Communique. LogMeIn&#39;s victory could have implications for 01&#39;s suit against thin client/PC virtualization software leade... https://seekingalpha.com/news/910771?source=tweet\" data-url=\"https://seekingalpha.com/news/910771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910731\" data-ts=\"1364327604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUQ\" target=\"_blank\">AUQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AuRico Gold (AUQ -8.2%) plunges after reporting soft Q4 gold production and a modest production...</a></h4><p>AuRico Gold (<a href=\"https://seekingalpha.com/symbol/AUQ\" title=\"AuRico Gold\">AUQ</a> <font color=\"red\">-8.2%</font>) plunges after reporting <a href=\"https://seekingalpha.com/currents/post/908991\" target=\"_blank\">soft Q4 gold production</a> and a modest production forecast for the year. Gold ounces produced fell to 40.7M for Q4 from 72.1M in the year-ago quarter, and sees 2013 gold production at 190M-220M oz. vs. 250.5M produced in  2012. AUQ had warned earlier that late-2012 production would suffer following a mining accident at its El Chanate mine in  Mexico.</p><div class=\"tiny-share-widget\" data-id=\"910731\" data-linked=\"AuRico Gold (AUQ -8.2%) plunges after reporting soft Q4 gold production and a modest production...\" data-tweet=\"$AUQ - AuRico Gold (AUQ -8.2%) plunges after reporting soft Q4 gold production and a modest production forecast for the year. Gold ounces produced fell to 40.7M for Q4 from 72.1M in the year-ago quarter, and sees 2013 gold production at 190M-220M oz. vs... https://seekingalpha.com/news/910731?source=tweet\" data-url=\"https://seekingalpha.com/news/910731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910711\" data-ts=\"1364327507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eli Lilly (LLY +1.2%) and its partner, Boehringer Ingelheim, say the European Medicines Agency...</a></h4><p>Eli Lilly (<a href=\"https://seekingalpha.com/symbol/LLY\" title=\"Eli Lilly and Company\">LLY</a> <font color=\"green\">+1.2%</font>) and its partner, Boehringer Ingelheim, say the European Medicines Agency has accepted for review a marketing authorization application for its investigational drug empagliflozin, for the treatment of type 2 diabetes mellitus in adults. A New Drug Application for the drug has already been submitted to the FDA in the United States earlier this year.</p><div class=\"tiny-share-widget\" data-id=\"910711\" data-linked=\"Eli Lilly (LLY +1.2%) and its partner, Boehringer Ingelheim, say the European Medicines Agency...\" data-tweet=\"$LLY - Eli Lilly (LLY +1.2%) and its partner, Boehringer Ingelheim, say the European Medicines Agency has accepted for review a marketing authorization application for its investigational drug empagliflozin, for the treatment of type 2 diabetes mellitus... https://seekingalpha.com/news/910711?source=tweet\" data-url=\"https://seekingalpha.com/news/910711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910691\" data-ts=\"1364326369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910691\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Johnson &amp;amp; Johnson (JNJ +1.5%) are trading at a fresh all-time high today,...</a></h4><p>Shares of Johnson &amp; Johnson (<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a> <font color=\"green\">+1.5%</font>) are trading at a fresh all-time high today, ratcheting up an ongoing a streak of higher highs since the beginning of the year after UBS <a href=\"http://www.mideasttime.com/johnson-johnson-given-new-87-00-price-target-at-ubs-ag-jnj/6232/\" target=\"_blank\">ups its price target</a> on the shares from  $81.00 to $87.00. If the stock closes out the week above $79.74, this could be it's longest winning streak in at least 20 years.</p><div class=\"tiny-share-widget\" data-id=\"910691\" data-linked=\"Shares of Johnson &amp;amp; Johnson (JNJ +1.5%) are trading at a fresh all-time high today,...\" data-tweet=\"$JNJ - Shares of Johnson &amp; Johnson (JNJ +1.5%) are trading at a fresh all-time high today, ratcheting up an ongoing a streak of higher highs since the beginning of the year after UBS ups its price target on the shares from $81.00 to $87.00. If the stock... https://seekingalpha.com/news/910691?source=tweet\" data-url=\"https://seekingalpha.com/news/910691\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910641\" data-ts=\"1364325027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOR\" target=\"_blank\">WOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Worthington Industries (WOR +3%) rises after Macquarie ups its rating on the company to...</a></h4><p>Worthington Industries (<a href=\"https://seekingalpha.com/symbol/WOR\" title=\"Worthington Industries, Inc.\">WOR</a> <font color=\"green\">+3%</font>) rises after Macquarie <a href=\"http://www.streetinsider.com/Upgrades/Macquarie+Upgrades+Worthington+Industries+%28WOR%29+to+Outperform/8210765.html\" target=\"_blank\">ups its rating</a> on the company to Outperform and hikes its target price to $35. The firm sees higher earnings, better product mix, and greater cash flow generation from dividends in the equity investment portfolio as solid drivers for growth. It also likes <a href=\"https://seekingalpha.com/symbol/WOR\" title=\"Worthington Industries, Inc.\">WOR</a>'s M&amp;A driven growth strategy focusing on higher-margin LPG/CNG tanks for alternative fuel markets and other high-value products.</p><div class=\"tiny-share-widget\" data-id=\"910641\" data-linked=\"Worthington Industries (WOR +3%) rises after Macquarie ups its rating on the company to...\" data-tweet=\"$WOR - Worthington Industries (WOR +3%) rises after Macquarie ups its rating on the company to Outperform and hikes its target price to $35. The firm sees higher earnings, better product mix, and greater cash flow generation from dividends in the equity... https://seekingalpha.com/news/910641?source=tweet\" data-url=\"https://seekingalpha.com/news/910641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910601\" data-ts=\"1364324077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSM\" target=\"_blank\">NSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fans of mortgage servicers have a look at how the sausage is made as Rob Chrisman passes along a...</a></h4>Fans of mortgage servicers have a look at how the sausage is made as Rob Chrisman <a href=\"http://thebasispoint.com/2013/03/25/mortgage-servicing-update-whos-ranked-best/\" target=\"_blank\">passes along</a> a couple of sales pitches for MSR portfolios. The servicers able to quickly scale up in size have an advantage as banks unload their portfolios for capital reasons and smaller outfits look to raise funds. After being savaged last week, <a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a> <font color=\"green\">+6.1%</font>, <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color=\"green\">+3%</font>, and NCT <font color=\"green\">+3.3%</font> are bouncing.<div class=\"tiny-share-widget\" data-id=\"910601\" data-linked=\"Fans of mortgage servicers have a look at how the sausage is made as Rob Chrisman passes along a...\" data-tweet=\"$NSM $NSM $OCN - Fans of mortgage servicers have a look at how the sausage is made as Rob Chrisman passes along a couple of sales pitches for MSR portfolios. The servicers able to quickly scale up in size have an advantage as banks unload their portfoli... https://seekingalpha.com/news/910601?source=tweet\" data-url=\"https://seekingalpha.com/news/910601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910581\" data-ts=\"1364323696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Oculus Innovative Sciences (OCLS +3%) tick higher today after the company says it&#39;s...</a></h4><p>Shares of Oculus Innovative Sciences (OCLS <font color=\"green\">+3%</font>) tick higher today after the company says it's been granted a CE Mark reclassification for its European formulation Dermacyn Wound Care. The newest indication is for the moistening of acute and chronic wounds and reducing the amount of microorganisms in the wound area. Additionally, the actives in Dermacyn are classified in Europe as medicinal substances that may have a local antimicrobial effect.</p><div class=\"tiny-share-widget\" data-id=\"910581\" data-linked=\"Shares of Oculus Innovative Sciences (OCLS +3%) tick higher today after the company says it&#39;s...\" data-tweet=\"$SNOA - Shares of Oculus Innovative Sciences (OCLS +3%) tick higher today after the company says it&#39;s been granted a CE Mark reclassification for its European formulation Dermacyn Wound Care. The newest indication is for the moistening of acute and chro... https://seekingalpha.com/news/910581?source=tweet\" data-url=\"https://seekingalpha.com/news/910581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910551\" data-ts=\"1364323185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto supplier stocks are seeing a minor rally after J.D. Power issues a strong outlook for U.S....</a></h4>Auto supplier stocks are seeing a minor rally after J.D. Power issues a <a href=\"http://www.freep.com/article/20130326/BUSINESS01/130326053/J-D-Power-and-Associates-U-S-auto-sales-New-York-Auto-Show\" target=\"_blank\">strong outlook</a> for U.S. auto sales. Advancers: Cooper Tire &amp; Rubber (NYSE:<a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a>) <font color=\"green\">+3.3%</font>, Delphi Automotive (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) <font color=\"green\">+2.8%</font>, Dana Holdings (NYSE:<a href='https://seekingalpha.com/symbol/DAN' title='Dana, Inc.'>DAN</a>) <font color=\"green\">+1.9%.</font><div class=\"tiny-share-widget\" data-id=\"910551\" data-linked=\"Auto supplier stocks are seeing a minor rally after J.D. Power issues a strong outlook for U.S....\" data-tweet=\"$CTB $CTB $DLPH - Auto supplier stocks are seeing a minor rally after J.D. Power issues a strong outlook for U.S. auto sales. Advancers: Cooper Tire &amp; Rubber (NYSE:CTB) +3.3%, Delphi Automotive (NYSE:DLPH) +2.8%, Dana Holdings (NYSE:DAN) +1.9%. https://seekingalpha.com/news/910551?source=tweet\" data-url=\"https://seekingalpha.com/news/910551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910501\" data-ts=\"1364322335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences (BDSI +5%) gains after announcing earlier today that it&#39;s entered into a...</a></h4><p>BioDelivery Sciences (<a href=\"https://seekingalpha.com/symbol/BDSI\" title=\"BioDelivery Sciences International, Inc.\">BDSI</a> <font color=\"green\">+5%</font>) gains after announcing earlier today that it's entered into a worldwide licensing agreement with privately held Arcion Therapeutics, where <a href=\"https://seekingalpha.com/symbol/BDSI\" title=\"BioDelivery Sciences International, Inc.\">BDSI</a> will develop and commercialize topical clonidine gel for the treatment of painful diabetic neuropathy and potentially other indications as well.</p><div class=\"tiny-share-widget\" data-id=\"910501\" data-linked=\"BioDelivery Sciences (BDSI +5%) gains after announcing earlier today that it&#39;s entered into a...\" data-tweet=\"$BDSI - BioDelivery Sciences (BDSI +5%) gains after announcing earlier today that it&#39;s entered into a worldwide licensing agreement with privately held Arcion Therapeutics, where BDSI will develop and commercialize topical clonidine gel for the treatmen... https://seekingalpha.com/news/910501?source=tweet\" data-url=\"https://seekingalpha.com/news/910501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910451\" data-ts=\"1364321075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRA\" target=\"_blank\">KRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kraton Performance Polymers (KRA -1.6%) slides today on an Oppenheimer downgrade to Market...</a></h4><p>Kraton Performance Polymers (<a href=\"https://seekingalpha.com/symbol/KRA\" title=\"Kraton Corporation\">KRA</a> <font color=\"red\">-1.6%</font>) slides today on an <a href=\"http://www.streetinsider.com/Downgrades/Oppenheimer+Downgrades+Kraton+Performance+Polymers+%28KRA%29+to+Perform/8210748.html\" target=\"_blank\">Oppenheimer downgrade</a> to Market Perform, saying it's expecting results to contract for the synthetic-rubber maker over the near-term. The firm notes that the stock has been highly correlated to the moves in butadiene, and spot prices have slumped over the past 6 weeks in  Asia. The chemical can't be inventoried, making it a leading indicator of demand, which currently appears quite weak.</p><div class=\"tiny-share-widget\" data-id=\"910451\" data-linked=\"Kraton Performance Polymers (KRA -1.6%) slides today on an Oppenheimer downgrade to Market...\" data-tweet=\"$KRA - Kraton Performance Polymers (KRA -1.6%) slides today on an Oppenheimer downgrade to Market Perform, saying it&#39;s expecting results to contract for the synthetic-rubber maker over the near-term. The firm notes that the stock has been highly correla... https://seekingalpha.com/news/910451?source=tweet\" data-url=\"https://seekingalpha.com/news/910451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910421\" data-ts=\"1364319895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The so-called government crackdown on illegal gambling junkets in Macau doesn&#39;t appear to be...</a></h4><p>The so-called government crackdown on illegal gambling junkets in Macau <a href=\"http://news.investors.com/business/032513-649229-macau-casinos-up-30-percent-in-march.htm\" target=\"_blank\">doesn't appear to be sticking</a> with reports indicating VIP gambling is strong in March. If there is a concern for Macau-related casino stocks, it might be broad macro-economic issues instead of the threat of a shutdown of junkets. Melco Crown (MPEL <font color=\"green\">+1.9%</font>), Wynn Resorts (<a href=\"https://seekingalpha.com/symbol/WYNN\" title=\"Wynn Resorts, Limited\">WYNN</a> <font color=\"green\">+2%</font>), Las Vegas Sands (<a href=\"https://seekingalpha.com/symbol/LVS\" title=\"Las Vegas Sands Corp.\">LVS</a> <font color=\"green\">+3.4%</font>), and MGM Resorts (<a href=\"https://seekingalpha.com/symbol/MGM\" title=\"MGM Resorts International\">MGM</a> <font color=\"green\">+0.3%</font>) have put in solid gains this week as <a href=\"http://news.investors.com/business/032513-649229-macau-casinos-up-30-percent-in-march.htm\" target=\"_blank\">revenue projections</a> from Macau keep getting rosier</p><div class=\"tiny-share-widget\" data-id=\"910421\" data-linked=\"The so-called government crackdown on illegal gambling junkets in Macau doesn&#39;t appear to be...\" data-tweet=\"$MLCO $MLCO $WYNN - The so-called government crackdown on illegal gambling junkets in Macau doesn&#39;t appear to be sticking with reports indicating VIP gambling is strong in March. If there is a concern for Macau-related casino stocks, it might be broad m... https://seekingalpha.com/news/910421?source=tweet\" data-url=\"https://seekingalpha.com/news/910421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910401\" data-ts=\"1364319492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWN\" target=\"_blank\">NEWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Energy Systems (OTC:NEWN -12%) swing wildly today, first surging +14% during the pre-opening...</a></h4><p>New Energy Systems (<a href=\"https://seekingalpha.com/symbol/NEWN\" title=\"New Energy Systems Group.\">OTC:NEWN</a> <font color=\"red\">-12%</font>) swing wildly today, first surging <font color=\"green\">+14%</font> during the pre-opening trade then dropping hard after its Chairman and CEO Weihe Yu withdrew an offer to take the company private for $1.30 per share.</p><div class=\"tiny-share-widget\" data-id=\"910401\" data-linked=\"New Energy Systems (OTC:NEWN -12%) swing wildly today, first surging +14% during the pre-opening...\" data-tweet=\"$NEWN - New Energy Systems (OTC:NEWN -12%) swing wildly today, first surging +14% during the pre-opening trade then dropping hard after its Chairman and CEO Weihe Yu withdrew an offer to take the company private for $1.30 per share. https://seekingalpha.com/news/910401?source=tweet\" data-url=\"https://seekingalpha.com/news/910401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910391\" data-ts=\"1364318941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Despite an ongoing trend of sluggish sales, Sonic (SONC +8.3%) rips higher as cost-cutting...</a></h4>Despite an ongoing trend of <a href=\"https://seekingalpha.com/currents/post/908391\" target=\"_blank\">sluggish sales</a>, Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='green'>+8.3%</font>) rips higher as cost-cutting initiatives start to pay off for the restaurant operator. For the current fiscal year, the company expects same-store sales to increase in the low single-digit range.<div class=\"tiny-share-widget\" data-id=\"910391\" data-linked=\"Despite an ongoing trend of sluggish sales, Sonic (SONC +8.3%) rips higher as cost-cutting...\" data-tweet=\"$SONC - Despite an ongoing trend of sluggish sales, Sonic (SONC +8.3%) rips higher as cost-cutting initiatives start to pay off for the restaurant operator. For the current fiscal year, the company expects same-store sales to increase in the low single-... https://seekingalpha.com/news/910391?source=tweet\" data-url=\"https://seekingalpha.com/news/910391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910361\" data-ts=\"1364318279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Omeros (OMER -9.2%) continue to slide today, despite earlier reporting positive data...</a></h4><p>Shares of Omeros (<a href=\"https://seekingalpha.com/symbol/OMER\" title=\"Omeros Corporation\">OMER</a> <font color=\"red\">-9.2%</font>) continue to slide today, despite <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/909261\">earlier reporting</a> positive data from Phase 1 clinical trials of its schizophrenia drug OMS824. Wedbush is out <a target=\"_blank\" href=\"http://www.streetinsider.com/FDA/Omeros+%28OMER%29+OMS824+Phase+1+Suggests+Potency%2C+Analyst+Says+Has+Blockbuster+Potential/8211923.html\">defending the shares</a> on the weakness, reiterating its Outperform rating and pointing out that early stage clinical data typically doesn't have a material impact on stock value. Phase 1 dosing results are encouraging, and provide a strong foundation for testing efficacy in Phase 2 trials, which it speculates could begin in H2 and provide results in H114.</p><div class=\"tiny-share-widget\" data-id=\"910361\" data-linked=\"Shares of Omeros (OMER -9.2%) continue to slide today, despite earlier reporting positive data...\" data-tweet=\"$OMER - Shares of Omeros (OMER -9.2%) continue to slide today, despite earlier reporting positive data from Phase 1 clinical trials of its schizophrenia drug OMS824. Wedbush is out defending the shares on the weakness, reiterating its Outperform rating ... https://seekingalpha.com/news/910361?source=tweet\" data-url=\"https://seekingalpha.com/news/910361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910331\" data-ts=\"1364316963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">An upbeat note from Brean Capital&#39;s Ananda Baruah is leading Seagate (STX +3%) and Western...</a></h4><p>An upbeat note from Brean Capital's Ananda Baruah is leading Seagate (<a href=\"https://seekingalpha.com/symbol/STX\" title=\"Seagate Technology\">STX</a> <font color=\"green\">+3%</font>) and Western Digital (<a href=\"https://seekingalpha.com/symbol/WDC\" title=\"Western Digital Corporation\">WDC</a> <font color=\"green\">+2.9%</font>) to rally. In spite of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/894621\">weak PC sales</a>, Baruah expects industry hard drive shipments to total 130M-135M in calendar Q1, down just slightly from Q4's 136M and in-line with guidance. Moreover, he sees the potential for 5%-10% 2H shipment growth, and ASPs and margins are seen benefiting from a mixture of better capacity utilization, stronger retail revenue, rising <a target=\"_blank\" href=\"http://reviews.cnet.com/8301-3132_7-57572453-98/seagate-ships-3rd-gen-hybrid-drive-now-called-sshd/\">hybrid drive</a> shipments, and a mix shift to enterprise and 500GB single-platter notebook drives. <a href=\"https://seekingalpha.com/symbol/LSI-OLD\" title=\"LSI Corp.\">LSI-OLD</a> <font color=\"green\">+1.4%</font>. <a href=\"https://seekingalpha.com/symbol/MRVL\" title=\"Marvell Technology Group, Ltd.\">MRVL</a> <font color=\"green\">+0.8%</font>.</p><div class=\"tiny-share-widget\" data-id=\"910331\" data-linked=\"An upbeat note from Brean Capital&#39;s Ananda Baruah is leading Seagate (STX +3%) and Western...\" data-tweet=\"$STX $STX $WDC - An upbeat note from Brean Capital&#39;s Ananda Baruah is leading Seagate (STX +3%) and Western Digital (WDC +2.9%) to rally. In spite of weak PC sales, Baruah expects industry hard drive shipments to total 130M-135M in calendar Q1, down jus... https://seekingalpha.com/news/910331?source=tweet\" data-url=\"https://seekingalpha.com/news/910331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910311\" data-ts=\"1364316860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTEK\" target=\"_blank\">PTEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910311\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: PTEK +30%. BVX +23%. OPXA +20%. LEDS +20%. IBCP +13%. DXYN +11%. GTAT...</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/PTEK\" title=\"PokerTek, Inc.\">PTEK</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/BVX\" title=\"Bovie Medical Corporation\">BVX</a> <font color=\"green\">+23%</font>. OPXA <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/LEDS\" title=\"SemiLEDs Corporation\">LEDS</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/IBCP\" title=\"Independent Bank Corporation\">IBCP</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/DXYN\" title=\"The Dixie Group, Inc.\">DXYN</a> <font color=\"green\">+11%</font>. GTAT <font color=\"green\">+11%</font>. APP <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/HGSH\" title=\"China HGS Real Estate, Inc.\">HGSH</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a> <font color=\"green\">+9%</font>.<br> <b>Midday top 10 losers:</b> <a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a> <font color=\"red\">-62%</font>. <a href=\"https://seekingalpha.com/symbol/FUQI\" title=\"Fuqi International, Inc.\">OTCPK:FUQI</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/GMAN\" title=\"Gordmans Stores\">GMAN</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/PGTI\" title=\"PGT Innovations, Inc.\">PGTI</a> <font color=\"red\">-14%</font>. STSI <font color=\"red\">-13%</font>. GMXR <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/STXS\" title=\"Stereotaxis, Inc.\">STXS</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/PRTS\" title=\"U.S. Auto Parts Network, Inc.\">PRTS</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/REED\" title=\"Reed's, Inc.\">REED</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/CSUN\" title=\"China Sunergy Co., Ltd.\">CSUN</a> <font color=\"red\">-8%</font>.<div class=\"tiny-share-widget\" data-id=\"910311\" data-linked=\"Midday top 10 gainers: PTEK +30%. BVX +23%. OPXA +20%. LEDS +20%. IBCP +13%. DXYN +11%. GTAT...\" data-tweet=\"$PTEK $PTEK $BVX - Midday top 10 gainers: PTEK +30%. BVX +23%. OPXA +20%. LEDS +20%. IBCP +13%. DXYN +11%. GTAT +11%. APP +11%. HGSH +9%. PGNX +9%. Midday top 10 losers: ZIOP -62%. OTCPK:FUQI -17%. GMAN -16%. PGTI -14%. STSI -13%. GMXR -11%. STXS -11%. ... https://seekingalpha.com/news/910311?source=tweet\" data-url=\"https://seekingalpha.com/news/910311\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910251\" data-ts=\"1364315495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNX\" target=\"_blank\">LMNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luminex (LMNX -4.5%) slips after Wedbush initiated coverage with a cautious Neutral rating and...</a></h4><p>Luminex (<a href=\"https://seekingalpha.com/symbol/LMNX\" title=\"Luminex Corporation\">LMNX</a> <font color=\"red\">-4.5%</font>) slips after Wedbush <a href=\"http://www.streetinsider.com/New+Coverage/UPDATE%3A+Wedbush+Starts+Luminex+%28LMNX%29+at+Neutral%3B+Lost+Traction+at+Labcorp/8209867.html\" target=\"_blank\">initiated coverage</a> with a cautious Neutral rating and $17 price target - near current levels. Wedbush says the company's business with Labcorp is slipping, and increasing competitive risks in the key respiratory diagnostics business, along with potential headwinds following the heavy Q113 flu season, leave its current multiple in question. The firm adds that the stock is presently trading at a premium to the life science tools group, and near-term expectations are too high.</p><div class=\"tiny-share-widget\" data-id=\"910251\" data-linked=\"Luminex (LMNX -4.5%) slips after Wedbush initiated coverage with a cautious Neutral rating and...\" data-tweet=\"$LMNX - Luminex (LMNX -4.5%) slips after Wedbush initiated coverage with a cautious Neutral rating and $17 price target - near current levels. Wedbush says the company&#39;s business with Labcorp is slipping, and increasing competitive risks in the key resp... https://seekingalpha.com/news/910251?source=tweet\" data-url=\"https://seekingalpha.com/news/910251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910231\" data-ts=\"1364314927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDK\" target=\"_blank\">LDK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LDK Solar (LDK -10.3%) falls to $1.06 on a day when it finished the sale of a 17M-share, 12.1%...</a></h4><p>LDK Solar (<a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"red\">-10.3%</font>) falls to $1.06 on a day when it finished the sale of a 17M-share, 12.1% stake to Hong Kong-based Fulai Investments. 12M newly-issued shares were sold at a price of $1.28, well below the $1.83 price the companies <a href=\"https://seekingalpha.com/currents/post/773621\" target=\"_blank\">initially agreed upon</a>. As previously announced, Fulai has the right to nominate two non-executive directors to the debt-laden solar manufacturer's board.</p><div class=\"tiny-share-widget\" data-id=\"910231\" data-linked=\"LDK Solar (LDK -10.3%) falls to $1.06 on a day when it finished the sale of a 17M-share, 12.1%...\" data-tweet=\"$LDK - LDK Solar (LDK -10.3%) falls to $1.06 on a day when it finished the sale of a 17M-share, 12.1% stake to Hong Kong-based Fulai Investments. 12M newly-issued shares were sold at a price of $1.28, well below the $1.83 price the companies initially a... https://seekingalpha.com/news/910231?source=tweet\" data-url=\"https://seekingalpha.com/news/910231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910221\" data-ts=\"1364314903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Monsanto (MON +3.7%) and DuPont (DD -1%) react differently to news the companies...</a></h4><p>Shares of Monsanto (<a href=\"https://seekingalpha.com/symbol/MON\" title=\"Monsanto Company\">MON</a> <font color=\"green\">+3.7%</font>) and DuPont (DD <font color=\"red\">-1%</font>) <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/03/26/monsanto-up-dupont-down-after-settlement-deal\" target=\"_blank\">react differently</a> to news the companies settled a patent dispute over technology rights for genetically modified seeds. The deal tosses out a $1B jury verdict DD was ordered to pay MON <a href=\"https://seekingalpha.com/currents/post/459401\" target=\"_blank\">last year</a>; instead, DD will make at least $1.75B in royalty payments over several years in return for broad access to develop products using MON's genetic technology.</p><div class=\"tiny-share-widget\" data-id=\"910221\" data-linked=\"Shares of Monsanto (MON +3.7%) and DuPont (DD -1%) react differently to news the companies...\" data-tweet=\"$MON $MON $DD - Shares of Monsanto (MON +3.7%) and DuPont (DD -1%) react differently to news the companies settled a patent dispute over technology rights for genetically modified seeds. The deal tosses out a $1B jury verdict DD was ordered to pay MON l... https://seekingalpha.com/news/910221?source=tweet\" data-url=\"https://seekingalpha.com/news/910221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910191\" data-ts=\"1364314322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIO\" target=\"_blank\">ABIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arca Biopharma (ABIO -6.2%) trades down today after the company filed a registration with the...</a></h4>Arca Biopharma (<a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a> <font color=\"red\">-6.2%</font>) trades down today after the company <a href=\"http://www.sec.gov/Archives/edgar/data/907654/000119312513124523/d507513ds1.htm\" target=\"_blank\">filed a registration</a> with the SEC to sell, from time to time, up to $20M of its stock and warrants.<div class=\"tiny-share-widget\" data-id=\"910191\" data-linked=\"Arca Biopharma (ABIO -6.2%) trades down today after the company filed a registration with the...\" data-tweet=\"$ABIO - Arca Biopharma (ABIO -6.2%) trades down today after the company filed a registration with the SEC to sell, from time to time, up to $20M of its stock and warrants. https://seekingalpha.com/news/910191?source=tweet\" data-url=\"https://seekingalpha.com/news/910191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910181\" data-ts=\"1364314079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS -3.3%) is apparently mortgaging future sales of its new weight-loss drug Qsymia in...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"red\">-3.3%</font>) is apparently mortgaging future sales of its new weight-loss drug Qsymia in exchange for up to $110M in new synthetic financing with an investment fund managed by Pharmakon Advisors. Under the terms, <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> will make an initial draw of $50M, with the option for an additional $60M at any time prior to December 31. In return, the drug developer will make quarterly payments ranging up to $5.3M or 25% of Qsymia sales, whichever is less. <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <a href=\"https://seekingalpha.com/market_currents/post/850001\" target=\"_blank\">has struggled</a> with its launch of the weight loss drug, netting just $2M in Q4 sales while posting a loss of  $56.7M.</p><div class=\"tiny-share-widget\" data-id=\"910181\" data-linked=\"Vivus (VVUS -3.3%) is apparently mortgaging future sales of its new weight-loss drug Qsymia in...\" data-tweet=\"$VVUS - Vivus (VVUS -3.3%) is apparently mortgaging future sales of its new weight-loss drug Qsymia in exchange for up to $110M in new synthetic financing with an investment fund managed by Pharmakon Advisors. Under the terms, VVUS will make an initial ... https://seekingalpha.com/news/910181?source=tweet\" data-url=\"https://seekingalpha.com/news/910181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910161\" data-ts=\"1364313411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUMZ\" target=\"_blank\">ZUMZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A weaker-than-anticipated reading on national chain store sales for the first three weeks of the...</a></h4>A weaker-than-anticipated reading on national chain store sales for the first three weeks of the month is enough to rattle the shares of a number of mall-based retailers. Though retail execs are pointing to the weather, trend-watchers are seeing a different story (<a href=\"http://www.floatingpath.com/wp-content/uploads/2012/08/ICSC-Goldman1.png\" target=\"_blank\">chart</a>). Decliners: <a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color=\"red\">-3.5%</font>, <a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color=\"red\">-2.8%</font>, LTD -1.5%, <a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color=\"red\">-2.8%</font>, <a href='https://seekingalpha.com/symbol/ANN' title='Ann, Inc.'>ANN</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color=\"red\">-2.5%</font>.<div class=\"tiny-share-widget\" data-id=\"910161\" data-linked=\"A weaker-than-anticipated reading on national chain store sales for the first three weeks of the...\" data-tweet=\"$ZUMZ $ZUMZ $AEO - A weaker-than-anticipated reading on national chain store sales for the first three weeks of the month is enough to rattle the shares of a number of mall-based retailers. Though retail execs are pointing to the weather, trend-watchers... https://seekingalpha.com/news/910161?source=tweet\" data-url=\"https://seekingalpha.com/news/910161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910151\" data-ts=\"1364313234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow Group (BRS +2.2%) is awarded a new contract to provide civilian search and rescue...</a></h4><p>Bristow Group (<a href=\"https://seekingalpha.com/symbol/BRS\" title=\"Bristow Group Inc.\">BRS</a> <font color=\"green\">+2.2%</font>) is awarded a new contract to provide civilian search and rescue services for all of the U.K. The provider of helicopter services to the offshore energy industry will supply at least 22 helicopters to be located at 10 bases across the country.</p><div class=\"tiny-share-widget\" data-id=\"910151\" data-linked=\"Bristow Group (BRS +2.2%) is awarded a new contract to provide civilian search and rescue...\" data-tweet=\"$BRS - Bristow Group (BRS +2.2%) is awarded a new contract to provide civilian search and rescue services for all of the U.K. The provider of helicopter services to the offshore energy industry will supply at least 22 helicopters to be located at 10 bas... https://seekingalpha.com/news/910151?source=tweet\" data-url=\"https://seekingalpha.com/news/910151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910111\" data-ts=\"1364312828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuPathe (PATH -6.6%) slips after its Q4 EPS loss came in much greater than expected. Net loss,...</a></h4><p>NuPathe (<a href=\"https://seekingalpha.com/symbol/PATH\" title=\"\">PATH</a> <font color=\"red\">-6.6%</font>) slips after its <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/909191\">Q4 EPS loss</a> came in much greater than expected. Net loss, including items, was $19.1M, wider than the loss reported in the prior year period. Despite the miss, CEO Armando Anido was upbeat in his comments, saying the company remains focused on securing commercial partners and preparing for the commercial launch of Zecuity, the first and only prescription migraine patch, which is expected in Q4.</p><div class=\"tiny-share-widget\" data-id=\"910111\" data-linked=\"NuPathe (PATH -6.6%) slips after its Q4 EPS loss came in much greater than expected. Net loss,...\" data-tweet=\"$TEVA - NuPathe (PATH -6.6%) slips after its Q4 EPS loss came in much greater than expected. Net loss, including items, was $19.1M, wider than the loss reported in the prior year period. Despite the miss, CEO Armando Anido was upbeat in his comments, sa... https://seekingalpha.com/news/910111?source=tweet\" data-url=\"https://seekingalpha.com/news/910111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"910051\" data-ts=\"1364311407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/910051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Threshold Pharmaceuticals (THLD +1.3%) gains on the back of Ziopharm&#39;s (ZIOP -63%) earlier...</a></h4><p>Threshold Pharmaceuticals (THLD <font color=\"green\">+1.3%</font>) gains on the back of Ziopharm's (<a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a> <font color=\"red\">-63%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/909061\">earlier announcement</a> that it's ending Phase 3 trials of palifosfamide after it failed to meet its primary endpoint. An article posted in Seeking Alpha last Friday infers that THLD's competing drug, TH-302, although similar to palifosfamide in molecular structure, is differentiated enough in nature that there is still sufficient reason to believe <a target=\"_blank\" href=\"https://seekingalpha.com/article/1294901-threshold-pharmaceuticals-a-derivative-trade-on-ziopharm-s-upcoming-data\">it could work</a>. Now, with <a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a>'s drug out of the running, TH-302's addressable market increases significantly. The company is due to release data from its own Phase III study early next year.</p><div class=\"tiny-share-widget\" data-id=\"910051\" data-linked=\"Threshold Pharmaceuticals (THLD +1.3%) gains on the back of Ziopharm&#39;s (ZIOP -63%) earlier...\" data-tweet=\"$MTEM $MTEM $ZIOP - Threshold Pharmaceuticals (THLD +1.3%) gains on the back of Ziopharm&#39;s (ZIOP -63%) earlier announcement that it&#39;s ending Phase 3 trials of palifosfamide after it failed to meet its primary endpoint. An article posted in Seeking Alpha... https://seekingalpha.com/news/910051?source=tweet\" data-url=\"https://seekingalpha.com/news/910051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909941\" data-ts=\"1364309470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACER\" target=\"_blank\">ACER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Opexa Therapeutics (OPXA +18%) spike higher today amid heavier-than-usual trading...</a></h4><p>Shares of Opexa Therapeutics (OPXA <font color=\"green\">+18%</font>) spike higher today amid heavier-than-usual trading volumes. News is light, but the company's 10-K is <a href=\"http://www.opexatherapeutics.com/index407e.html?page=sec&amp;section=investors\" target=\"_blank\">due out tomorrow</a>, and it could be the catalyst behind the move as investors are anticipating a number of developments in its pipeline. Additionally, an <a href=\"https://seekingalpha.com/article/1299761-opexa-a-significant-growth-opportunity-for-short-term-traders-and-long-term-investors\" target=\"_blank\">article in Seeking Alpha </a>this morning says the stock is poised to break out for several reasons, citing the strength of its new partnership agreement with Merck Serono, new developments with its lead product candidate, Tcelna, and signs of a large, active institutional buyer in the market.</p><div class=\"tiny-share-widget\" data-id=\"909941\" data-linked=\"Shares of Opexa Therapeutics (OPXA +18%) spike higher today amid heavier-than-usual trading...\" data-tweet=\"$ACER - Shares of Opexa Therapeutics (OPXA +18%) spike higher today amid heavier-than-usual trading volumes. News is light, but the company&#39;s 10-K is due out tomorrow, and it could be the catalyst behind the move as investors are anticipating a number o... https://seekingalpha.com/news/909941?source=tweet\" data-url=\"https://seekingalpha.com/news/909941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909891\" data-ts=\"1364308448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citing &quot;increased margin and subscriber assumptions,&quot; Pac Crest&#39;s Andy Hargreaves is raising his...</a></h4><p>Citing \"increased margin and subscriber assumptions,\" Pac Crest's <a href=\"http://www.marketwatch.com/story/netflix-rises-as-pacific-crest-pumps-up-target-2013-03-26\" target=\"_blank\">Andy Hargreaves</a> is raising his PT for Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a> <font color=\"green\">+3.9%</font>) to $225 from $160. \"Netflix's huge database of subscriber viewing habits should allow it to invest in original content where it will be most effective, while purchasing third-party content across an array of genres.\" Netflix execs have long <a href=\"http://www.nytimes.com/2013/02/25/business/media/for-house-of-cards-using-big-data-to-guarantee-its-popularity.html?pagewanted=all&amp;_r=0\" target=\"_blank\">talked up </a>the company's use of data to make content decisions. Hargreaves sees Netflix having 36M U.S. streaming subs at the end of 2015, up from 27.2M at the end of 2012. (<a href=\"https://seekingalpha.com/currents/post/179901\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"909891\" data-linked=\"Citing &quot;increased margin and subscriber assumptions,&quot; Pac Crest&#39;s Andy Hargreaves is raising his...\" data-tweet=\"$NFLX - Citing &quot;increased margin and subscriber assumptions,&quot; Pac Crest&#39;s Andy Hargreaves is raising his PT for Netflix (NFLX +3.9%) to $225 from $160. &quot;Netflix&#39;s huge database of subscriber viewing habits should allow it to invest in original content w... https://seekingalpha.com/news/909891?source=tweet\" data-url=\"https://seekingalpha.com/news/909891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909881\" data-ts=\"1364307979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRQ\" target=\"_blank\">TRQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turquoise Hill Resources (TRQ -2%) is lower after reporting a Q4 loss of $0.17/share and...</a></h4><p>Turquoise Hill Resources (<a href=\"https://seekingalpha.com/symbol/TRQ\" title=\"Turquoise Hill Resources Ltd.\">TRQ</a> <font color=\"red\">-2%</font>) is lower after reporting a <a href=\"http://finance.yahoo.com/news/turquoise-hill-resources-announces-financial-213852510.html\" target=\"_blank\">Q4 loss</a> of $0.17/share and revenues of $41M, results that fell well short of analysts expectations. TRQ says first concentrate at the Oyu Tolgoi mine was produced Jan. 31, and commercial production is expected to start by the end of June subject to the resolution of issues being discussed with Mongolia's government.</p><div class=\"tiny-share-widget\" data-id=\"909881\" data-linked=\"Turquoise Hill Resources (TRQ -2%) is lower after reporting a Q4 loss of $0.17/share and...\" data-tweet=\"$TRQ - Turquoise Hill Resources (TRQ -2%) is lower after reporting a Q4 loss of $0.17/share and revenues of $41M, results that fell well short of analysts expectations. TRQ says first concentrate at the Oyu Tolgoi mine was produced Jan. 31, and commerci... https://seekingalpha.com/news/909881?source=tweet\" data-url=\"https://seekingalpha.com/news/909881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909871\" data-ts=\"1364307516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James upgrades BroadSoft (BSFT +7.8%) to Market Perform a day after shares took off in...</a></h4><p>Raymond James upgrades BroadSoft (BSFT <font color=\"green\">+7.8%</font>) to Market Perform a day after <a href=\"https://seekingalpha.com/currents/post/907991\" target=\"_blank\">shares took off</a> in response to the Oracle-Tekelec deal. The provider of unified communications software/services for carriers is now <font color=\"green\">up 15%</font> on the week, but still <font color=\"red\">down 20%</font> YTD.</p><div class=\"tiny-share-widget\" data-id=\"909871\" data-linked=\"Raymond James upgrades BroadSoft (BSFT +7.8%) to Market Perform a day after shares took off in...\" data-tweet=\"$CSCO - Raymond James upgrades BroadSoft (BSFT +7.8%) to Market Perform a day after shares took off in response to the Oracle-Tekelec deal. The provider of unified communications software/services for carriers is now up 15% on the week, but still down 2... https://seekingalpha.com/news/909871?source=tweet\" data-url=\"https://seekingalpha.com/news/909871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909761\" data-ts=\"1364305991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Sustained content increases look likely, including at top customers Samsung and Apple . RFMD...</a></h4><p>\"Sustained content increases look likely, including at top customers Samsung and Apple ... RFMD appears well positioned to capitalize on expanding RF complexity with its 'systems-level' approach.\" <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3446822/update-oppenheimer-upgrades-rf-micro-devices-to-outperfo\">writes</a> Oppenheimer's Rick Schafer, explaining his <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/909331\">upgrade</a> of RF Micro (RFMD <font color=\"green\">+8.2%</font>). He's raising his estimates on account of the chipmaker's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/891741\">Galaxy S IV design wins</a> and high-end tuner/RF switch opportunities. Shares are close to their 52-week high. Skyworks (<a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"green\">+2.1%</font>) and Anadigics (<a href=\"https://seekingalpha.com/symbol/ANAD\" title=\"ANADIGICS, Inc.\">ANAD</a> <font color=\"green\">+3.1%</font>) appear to be rallying in sympathy.</p><div class=\"tiny-share-widget\" data-id=\"909761\" data-linked=\"&quot;Sustained content increases look likely, including at top customers Samsung and Apple . RFMD...\" data-tweet=\"$QRVO $QRVO $SWKS - &quot;Sustained content increases look likely, including at top customers Samsung and Apple . RFMD appears well positioned to capitalize on expanding RF complexity with its &#39;systems-level&#39; approach.&quot; writes Oppenheimer&#39;s Rick Schafer, exp... https://seekingalpha.com/news/909761?source=tweet\" data-url=\"https://seekingalpha.com/news/909761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909751\" data-ts=\"1364305849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPT\" target=\"_blank\">GPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gramercy Capital (GKK) rises 1.6% in early trade as SA Pro author Chris DeMuth updates his...</a></h4><p>Gramercy Capital (GKK) <font color=\"green\">rises 1.6%</font> in early trade as SA Pro author Chris DeMuth <a href=\"https://seekingalpha.com/article/1296571-broken-atm-machines-gramercy-capital-part-iii\" target=\"_blank\">updates his valuation model</a> following the company's <a href=\"https://seekingalpha.com/currents/post/899671\" target=\"_blank\">business plan update</a> last week, and finds the stock could be worth $8-$11/share by year's end following a capital raise and then successful deployment of that capital. Waiting to buy the stock until the company initiates a dividend will prove a costly strategy, he says. (<a href=\"https://seekingalpha.com/article/1076551-our-best-investment-idea-for-2013-gramercy-capital\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"909751\" data-linked=\"Gramercy Capital (GKK) rises 1.6% in early trade as SA Pro author Chris DeMuth updates his...\" data-tweet=\"$GPT - Gramercy Capital (GKK) rises 1.6% in early trade as SA Pro author Chris DeMuth updates his valuation model following the company&#39;s business plan update last week, and finds the stock could be worth $8-$11/share by year&#39;s end following a capital r... https://seekingalpha.com/news/909751?source=tweet\" data-url=\"https://seekingalpha.com/news/909751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909661\" data-ts=\"1364303754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: THLD +8%. CTIC +6%. Losers: ZIOP -62%. PLCE -6%. PATH -6%.</a></h4><b>Premarket gainers:</b> THLD <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+6%</font>. <br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a> <font color=\"red\">-62%</font>. <a href=\"https://seekingalpha.com/symbol/PLCE\" title=\"The Children's Place Retail Stores, Inc.\">PLCE</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/PATH\" title=\"\">PATH</a> <font color=\"red\">-6%</font>.<div class=\"tiny-share-widget\" data-id=\"909661\" data-linked=\"Premarket gainers: THLD +8%. CTIC +6%. Losers: ZIOP -62%. PLCE -6%. PATH -6%.\" data-tweet=\"$MTEM $MTEM $CTIC - Premarket gainers: THLD +8%. CTIC +6%. Losers: ZIOP -62%. PLCE -6%. PATH -6%. https://seekingalpha.com/news/909661?source=tweet\" data-url=\"https://seekingalpha.com/news/909661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909621\" data-ts=\"1364303586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Piper&#39;s upgrade of Electronic Arts: Analyst Michael Olson is encouraged by EA&#39;s CEO...</a></h4><a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3446514/update-piper-jaffray-upgrades-electronic-arts-to-overwei\" target=\"_blank\">More</a> on Piper's <a href=\"https://seekingalpha.com/currents/post/909021\" target=\"_blank\">upgrade</a> of Electronic Arts: Analyst Michael Olson is encouraged by EA's CEO transition, greater clarity about next-gen consoles, the calendar Q4 launch of <em>Battlefield 4</em>, and (given the popularity of EA's <em>FIFA</em> franchise) the 2014 World Cup. Olson admits shares were lower when he downgraded them in January on concerns about weak Dec. and March quarter results (<a href=\"https://seekingalpha.com/currents/post/894891\" target=\"_blank\">proven justified</a>), but argues the aforementioned factors have led to a better risk/reward. <a href=\"https://seekingalpha.com/symbol/EA\" title=\"Electronic Arts Inc.\">EA</a> <font color=\"green\">+2.8%</font>.<div class=\"tiny-share-widget\" data-id=\"909621\" data-linked=\"More on Piper&#39;s upgrade of Electronic Arts: Analyst Michael Olson is encouraged by EA&#39;s CEO...\" data-tweet=\"$EA - More on Piper&#39;s upgrade of Electronic Arts: Analyst Michael Olson is encouraged by EA&#39;s CEO transition, greater clarity about next-gen consoles, the calendar Q4 launch of Battlefield 4, and (given the popularity of EA&#39;s FIFA franchise) the 2014 Wo... https://seekingalpha.com/news/909621?source=tweet\" data-url=\"https://seekingalpha.com/news/909621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909511\" data-ts=\"1364302135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">When Elon Musk tweets, do people listen? Shares of Tesla Motors (NASDAQ:TSLA) are still holding...</a></h4><p>When Elon Musk <a href=\"https://twitter.com/elonmusk/status/316260319360061440\" target=\"_blank\">tweets</a>, do people listen? Shares of Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) are still holding up even though the electric vehicle automaker's CEO <a href=\"https://seekingalpha.com/currents/post/908311\" target=\"_blank\">tipped off</a> a potential secondary offering of stock yesterday. Though effusive confidence by a CEO is a nice touch, some traders are <a href=\"https://seekingalpha.com/article/1300031-does-the-tweet-from-tesla-s-ceo-mean-a-secondary-offering-looms?source=kizur\" target=\"_blank\">warning</a> that Tesla's stock price is looking even riskier with the latest development. Look for Elon Musk to give some enticing details on development of the Model X to help smooth over any news of a capital raise. TSLA <font color=\"green\">+0.2%</font> premarket to $37.60.</p><div class=\"tiny-share-widget\" data-id=\"909511\" data-linked=\"When Elon Musk tweets, do people listen? Shares of Tesla Motors (NASDAQ:TSLA) are still holding...\" data-tweet=\"$TSLA - When Elon Musk tweets, do people listen? Shares of Tesla Motors (NASDAQ:TSLA) are still holding up even though the electric vehicle automaker&#39;s CEO tipped off a potential secondary offering of stock yesterday. Though effusive confidence by a CEO... https://seekingalpha.com/news/909511?source=tweet\" data-url=\"https://seekingalpha.com/news/909511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909361\" data-ts=\"1364299938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OUTR\" target=\"_blank\">OUTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coinstar (CSTR -0.4%) looks ripe to run higher even after shares have run up a double-digit gain...</a></h4><p>Coinstar (<a href=\"https://seekingalpha.com/symbol/CSTR\" title=\"CapStar Financial Holdings\">CSTR</a> <font color=\"red\">-0.4%</font>) looks ripe to <a href=\"http://online.barrons.com/article/SB50001424052748704882404578382602323476518.html?ru=yahoo&amp;mod=yahoobarrons&amp;cb=logged0.6368207547347993\" target=\"_blank\">run higher</a> even after shares have run up a double-digit gain this month, according to B. Riley. The investment firm's bull thesis is centered on the idea that investors have under-appreciated the sheer size of the DVD rental market and the opportunities for Redbox on the digital side. CSTR <font color=\"green\">+2.8%</font> premarket to $57.50.</p><div class=\"tiny-share-widget\" data-id=\"909361\" data-linked=\"Coinstar (CSTR -0.4%) looks ripe to run higher even after shares have run up a double-digit gain...\" data-tweet=\"$OUTR - Coinstar (CSTR -0.4%) looks ripe to run higher even after shares have run up a double-digit gain this month, according to B. Riley. The investment firm&#39;s bull thesis is centered on the idea that investors have under-appreciated the sheer size of... https://seekingalpha.com/news/909361?source=tweet\" data-url=\"https://seekingalpha.com/news/909361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909271\" data-ts=\"1364298715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLCE\" target=\"_blank\">PLCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Children&#39;s Place (NASDAQ:PLCE) slump, down 5.9% premarket, after the retailer issues...</a></h4><p>Shares of Children's Place (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PLCE\" title=\"The Children's Place Retail Stores, Inc.\">PLCE</a>) slump, down 5.9% premarket, after the retailer issues guidance for Q1 well-below the estimates of analysts. The company expects sales to fall off at a negative high single-digit pace during the period.</p><div class=\"tiny-share-widget\" data-id=\"909271\" data-linked=\"Shares of Children&#39;s Place (NASDAQ:PLCE) slump, down 5.9% premarket, after the retailer issues...\" data-tweet=\"$PLCE - Shares of Children&#39;s Place (NASDAQ:PLCE) slump, down 5.9% premarket, after the retailer issues guidance for Q1 well-below the estimates of analysts. The company expects sales to fall off at a negative high single-digit pace during the period. https://seekingalpha.com/news/909271?source=tweet\" data-url=\"https://seekingalpha.com/news/909271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909191\" data-ts=\"1364297852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\"> NuPathe Inc (PATH): Q4 EPS of -$1.15. Shares +3.8% premarket. (PR)</a></h4><b> NuPathe Inc (<a href=\"https://seekingalpha.com/symbol/PATH\" title=\"\">PATH</a>):</b> Q4 EPS of -$1.15. Shares  <font color=\"green\">+3.8%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"909191\" data-linked=\" NuPathe Inc (PATH): Q4 EPS of -$1.15. Shares +3.8% premarket. (PR)\" data-tweet=\"$TEVA - NuPathe Inc (PATH): Q4 EPS of -$1.15. Shares +3.8% premarket. (PR) https://seekingalpha.com/news/909191?source=tweet\" data-url=\"https://seekingalpha.com/news/909191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909061\" data-ts=\"1364296623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ziopharm Oncology (NASDAQ:ZIOP) -59% after reporting the failure of palifosfamide in its Phase 3...</a></h4><p>Ziopharm Oncology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a>) <font color=\"red\">-59%</font> after reporting the failure of palifosfamide in its Phase 3 trial, and saying it is pulling development of the treatment. Kudos to Adam Feurstein's source who was certain enough of the test results <a href=\"https://seekingalpha.com/currents/post/904771\" target=\"_blank\">to short the stock </a>last week.</p><div class=\"tiny-share-widget\" data-id=\"909061\" data-linked=\"Ziopharm Oncology (NASDAQ:ZIOP) -59% after reporting the failure of palifosfamide in its Phase 3...\" data-tweet=\"$ZIOP - Ziopharm Oncology (NASDAQ:ZIOP) -59% after reporting the failure of palifosfamide in its Phase 3 trial, and saying it is pulling development of the treatment. Kudos to Adam Feurstein&#39;s source who was certain enough of the test results to short t... https://seekingalpha.com/news/909061?source=tweet\" data-url=\"https://seekingalpha.com/news/909061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"909001\" data-ts=\"1364293016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLCE\" target=\"_blank\">PLCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/909001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Children&#39;s Place (NASDAQ:PLCE): Q4 EPS of $1.15 beats by $0.11. Revenue of $509.2M beats by...</a></h4><b>Children's Place (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PLCE\" title=\"The Children's Place Retail Stores, Inc.\">PLCE</a>):</b> Q4 EPS of $1.15 <font color=\"green\">beats by $0.11</font>. Revenue of $509.2M <font color=\"green\">beats by $13.16M</font>. Shares  <font color=\"red\">-4.3%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"909001\" data-linked=\"Children&#39;s Place (NASDAQ:PLCE): Q4 EPS of $1.15 beats by $0.11. Revenue of $509.2M beats by...\" data-tweet=\"$PLCE - Children&#39;s Place (NASDAQ:PLCE): Q4 EPS of $1.15 beats by $0.11. Revenue of $509.2M beats by $13.16M. Shares -4.3% AH. (PR) https://seekingalpha.com/news/909001?source=tweet\" data-url=\"https://seekingalpha.com/news/909001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 AM </div></div></li>","count":51,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}